Facebook Tells Pharma Brands They Must Allow Comments
It was an important and clearly predictable step from Facebook to tell pharma brands that they must allow comments on their Facebook pages. Andrew Spong, Marc Monseau and Alex Butler had quite positive comments about that in a Facebook discussion. We will certainly include this in our open-access guide for pharma companies.
Pharma brand marketers that disable comments on their Facebook pages are in for a change. As predicted, Facebook will no longer allow pharma brands – which are typically highly risk averse when it comes to discussions about their drugs and products in social media environments – to turn off commenting on their pages.
In an effort to keep Facebook a forum for open dialogue, the company will not allow admins of new pages to disable commenting on their pages, according to a company spokesperson. In addition, brands with preexisting pages will be required to allow comments after August 15, according to an email sent by Facebook reps notifying clients of the changes. The email was posted yesterday to the Intouch Soul blog, associated with pharma marketing agency Intouch Solutions.
There is still a long way to go before Pharma embraces social media. Some are now starting to play with it, but they lack strategic direction. It has not helped that the FDA have failed to give any meaningful guidelines.
I think Alan you should definitely have a look around! Pharma are already using Social Media and there is a lot of very good things that have been created. Guidelines would be welcomed indeed by the industry but it has not – in any way – prevented them to embrace social media.
Ramos
i like thi$ page
Oh
Ok
Salamualaikum.To boko haram saikumanabayani gameda kiristoci wadanda akekamawa sunadasabom anajeriya.
Picture
Since the FDA allowed relatively unhindered consumer-oriented advertisements by pharma companies (which regularly interrupt our family TV watching time with ED ads for those infuriatingly awkward family moments), it seems appropriate that facebook should require commenting on the pharma company’s facebook page. The exchange of information should be a two-way street, and only right that consumers should be able to comment back on big pharma’s social network pages.
I have to agree!
facebook
Hello,I,m fine
thank for u dear